Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction

Gedske Daugaard; Ulrik Lassen; Peter Bie; Erling Bjerregaard Pedersen; Kaare Troels Jensen; Ulrik Abildgaard; Birger Hesse; Andreas Kjaer

doi:10.1016/j.ejheart.2004.03.009

Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction

Gedske Daugaard, Ulrik Lassen, Peter Bie, Erling Bjerregaard Pedersen, Kaare Troels Jensen, Ulrik Abildgaard, Birger Hesse, Andreas Kjaer

Department of Clinical Physiology and Nuclear Medicine

119 Citations (Scopus)

Abstract

The use of anthracyclines in treatment of cancer is limited by cardiotoxicity of these compounds and may lead to heart failure. Therefore monitoring of cardiac function is necessary during therapy.

Original language	English
Journal	European Journal of Heart Failure
Volume	7
Issue number	1
Pages (from-to)	87-93
Number of pages	7
ISSN	1388-9842
DOIs	https://doi.org/10.1016/j.ejheart.2004.03.009
Publication status	Published - 2005

Keywords

Adolescent
Adult
Aged
Antibiotics, Antineoplastic
Atrial Natriuretic Factor
Epirubicin
Female
Humans
Male
Middle Aged
Natriuretic Peptide, Brain
Neoplasms
Predictive Value of Tests
Protein Precursors
Stroke Volume
Ventricular Function, Left

Access to Document

10.1016/j.ejheart.2004.03.009

Cite this

@article{19b0aa4efe574a34bb15ef79118fa544,

title = "Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction",

abstract = "The use of anthracyclines in treatment of cancer is limited by cardiotoxicity of these compounds and may lead to heart failure. Therefore monitoring of cardiac function is necessary during therapy.",

keywords = "Adolescent, Adult, Aged, Antibiotics, Antineoplastic, Atrial Natriuretic Factor, Epirubicin, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Neoplasms, Predictive Value of Tests, Protein Precursors, Stroke Volume, Ventricular Function, Left",

author = "Gedske Daugaard and Ulrik Lassen and Peter Bie and Pedersen, \{Erling Bjerregaard\} and Jensen, \{Kaare Troels\} and Ulrik Abildgaard and Birger Hesse and Andreas Kjaer",

year = "2005",

doi = "10.1016/j.ejheart.2004.03.009",

language = "English",

volume = "7",

pages = "87--93",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction

AU - Daugaard, Gedske

AU - Lassen, Ulrik

AU - Bie, Peter

AU - Pedersen, Erling Bjerregaard

AU - Jensen, Kaare Troels

AU - Abildgaard, Ulrik

AU - Hesse, Birger

AU - Kjaer, Andreas

PY - 2005

Y1 - 2005

N2 - The use of anthracyclines in treatment of cancer is limited by cardiotoxicity of these compounds and may lead to heart failure. Therefore monitoring of cardiac function is necessary during therapy.

AB - The use of anthracyclines in treatment of cancer is limited by cardiotoxicity of these compounds and may lead to heart failure. Therefore monitoring of cardiac function is necessary during therapy.

KW - Adolescent

KW - Adult

KW - Aged

KW - Antibiotics, Antineoplastic

KW - Atrial Natriuretic Factor

KW - Epirubicin

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Natriuretic Peptide, Brain

KW - Neoplasms

KW - Predictive Value of Tests

KW - Protein Precursors

KW - Stroke Volume

KW - Ventricular Function, Left

UR - https://www.scopus.com/pages/publications/11844290705

U2 - 10.1016/j.ejheart.2004.03.009

DO - 10.1016/j.ejheart.2004.03.009

M3 - Journal article

C2 - 15642537

SN - 1388-9842

VL - 7

SP - 87

EP - 93

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 1

ER -

Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this